RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression

Zhenyu Liu(Guangxi Normal University), Zhi‐Nan Chen(National Medical Products Administration)
Theranostics
January 1, 2019
Cited by 88


Related Papers